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Severe Hypercapnia in Critically Ill Adult Cystic 
Fibrosis Patients
Hassan S. Sheikha, Noel Dexter Tiangcoa, Christopher Harrella, 
Robert L. Vendera, b
Abstract
Background:  Cystic fibrosis (CF) is a monogenetic autosomal 
recessive multi-organ disease affecting approximately 50,000 pa-
tients worldwide. Overall median survival is continually increasing 
but pulmonary disease remains the most common cause of death. 
Guidelines have been published in relation to the outpatient main-
tenance of lung health for CF patients and treatment of acute lung 
exacerbations but little information exists about the management 
of the critically ill CF patient. Invasive mechanical ventilation in 
CF patients with acute respiratory failure is associated with poor 
outcome and high mortality.
Methods:  Retrospective analysis of adult patients with CF who re-
quired endotracheal intubation and invasive mechanical ventilation 
in the Medical Intensive Care Unit (MICU).
Results:  Between the years 2003 - 2009, 14 adult patients with CF 
required endotracheal intubation and invasive mechanical ventila-
tion in the Medical Intensive Care Unit (MICU) of the Penn State 
Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA. 
Eleven patients died in the MICU because of progressive respira-
tory failure and inability to liberate from mechanical ventilation. 
Seven individuals consistently manifested arterial partial pressures 
of carbon dioxide (PaCO2) greater than 20.00 kPa despite high lev-
els of conventional modes of mechanical ventilation.
Conclusions:  Intubated CF patients with respiratory failure have a 
high mortality rate. Based on our experience, multiple factors con-
tribute to severe hypercapnia and the effectiveness of conventional 
modes of mechanical ventilation in many of these patients is lim-
ited.
Keywords:  Cystic fibrosis; Mechanical ventilation; Critical care; 
Hypercapnia; Respiratory failure
Introduction
Cystic fibrosis (CF) is a monogenetic autosomal recessive 
multi-organ disease affecting approximately 50,000 patients 
worldwide. Despite the increasing longevity and improving 
median age of survival of CF patients, for the vast majority, 
CF remains a fatal disease. As the CF population becomes 
older and especially with advancements in lung transplan-
tation, more patients are being admitted and cared for in 
critical care settings. Unfortunately, particularly for those 
requiring endotracheal intubation and invasive mechanical 
ventilation for respiratory failure, the outcome continues to 
be poor [1-3].
Little information exists in relation to specific aspects 
of the intensive care management of these complex patients, 
especially  with  regard  to  invasive  mechanical  ventilation 
[4]. This is in contrast to pulmonary entities such as asthma, 
chronic obstructive pulmonary disease (COPD), and acute 
respiratory distress syndrome (ARDS) for which ventilator 
strategies have been recommended, based on the current un-
derstanding of their underlying pathophysiologic processes, 
with the aim of providing adequate gas exchange while mini-
mizing adverse effects [5, 6]. In this paper, we present our 
experience with CF patients requiring invasive mechanical 
ventilation,  hoping  to  expand  the  understanding  of  these 
critically ill patients.
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Materials and Methods
In a retrospective chart review, 7 adult patients with CF who 
were endotracheally intubated and mechanically ventilated 
in  the  Medical  Intensive  Care  Unit  (MICU)  of  the  Penn 
State Milton S. Hershey Medical Center within the last 7 
years  were  selected.  Demographic  information,  arterial 
blood gas (ABG) data, and respiratory-related parameters 
were  collected.  ABG  measurements  were  obtained  from 
samples of heparinized arterial blood and partial pressures 
of  carbon  dioxide  (PaCO2)  and  oxygen  (PaO2)  measured 
using Automated Instruments with a reported linear range 
of accuracy for PaCO2 as high as 33.33 kPa. Dead space 
fraction  was  estimated  for  each  patient  using  measured 
PaCO2 and minute ventilation (VE) with the assumption that 
CO2 production (VCO2) for each was 250 mL/min [7, 8]. 
All laboratory determinations were made during periods of 
direct observation at times of worsening clinical status in 
hospitalized patients in a monitored environment. None of the 
evaluations were obtained at a time of unexpectedly finding 
any patient in a “code” situation or clinically unanticipated 
deterioration. This study was performed in full compliance 
with regulations and requirements for human investigation in 
relation to decedents’ protected health information through 
the  Human  Subjects  Protection  Office  of  the  Penn  State 
Milton S. Hershey Medical Center.
 
Results
From 2003 to 2009, 14 adults (age 18 years or older) with CF 
requiring endotracheal intubation and invasive mechanical 
ventilation were admitted to the MICU at the Penn State Mil-
ton S. Hershey Medical Center. All patients received some 
mode  of  standard  conventional  ventilation:  intermittent 
mandatory ventilation-pressure control (IMV-PC) including 
Airway  Pressure  Release Ventilation  (APRV),  continuous 
mandatory  ventilation-pressure  control  (CMV-PC),  inter-
mittent mandatory ventilation-dual control (IMV-DC), and 
continuous mandatory ventilation-dual control (CMV-DC) 
[9]. The dual control modes included both pressure regulated 
volume control (PRVC) and autoflow. These 14 patients ac-
counted for 364 MICU days and 309 ventilator days. Eleven 
patients died during their MICU stay because of progressive 
respiratory failure and inability to liberate from mechanical 
ventilation, 1 patient died from septic shock secondary to 
acute pyelonephritis, 1 patient was discharged to home hos-
pice care and subsequently died, while another survived and 
was discharged home in improved condition.  
The 11 patients who died from respiratory causes and 
the lone survivor demonstrated marked elevations in PaCO2. 
Furthermore,  7  of  those  patients  consistently  manifested 
PaCO2 measurements above 20.00 kPa (range 22.66-33.06 
kPa). The 7 patients had been admitted to the ICU because of 
hypercapnic respiratory failure secondary to an acute infec-
tious pulmonary exacerbation. All 7 died after medical sup-
port was withdrawn in compliance with requests of family. 
Patient demographics and physiological information of these 
patients are reported in Table 1.
Discussion
  
While prior studies have shown that non-invasive ventilation 
has decreased the mortality rate of critically ill CF patients, 
survival following institution of invasive ventilation remains 
poor [1-3]. Our findings are in agreement with the reported 
high mortality associated with invasive ventilation. Other 
predictors of poor outcome include rapid decline in FEV1 
leading up to the time of ICU admission, prior Burkholderia 
cepacia complex lung infection, and the severity of the acute 
exacerbation [10]. Consistent with previous publications, fe-
male gender, malnutrition, and B. cepacia syndrome were 
also significant factors associated with a fatal outcome [11, 
12]. Potentially reversible complications of CF-lung disease 
such as spontaneous pneumothorax or massive hemoptysis 
do not invariably portend a predictable fatal outcome but 
were not identified in the patients in this study [11].
The magnitude of elevations in PaCO2 for these 7 re-
ported patients far exceeds measurements previously report-
ed in either patients with CF or COPD even during acute 
exacerbations [13]. In fact there is only a single notation of 
three patients with PaCO2 measurements above 14.40 kPa 
in a review that included 65 admissions to the ICU for re-
spiratory failure, 32 of them requiring invasive mechanical 
ventilation [11]. In addition, a second study of only 8 adult 
patients with CF who required invasive ventilation reported 
a mean PaCO2 of 13.60 ± 8.00 kPa [1].
The 7 patients in this paper demonstrated severe hyper-
capnia. These findings are likely contributed to by several 
factors: First, dead space fraction was markedly increased 
for every patient. Calculated ratios of dead space ventilation 
to tidal volume (Vd/Vt) consistently exceeded 70%, a level 
of abnormality predictive of failure to maintain spontaneous 
ventilation and adequate gas exchange without mechanical 
ventilatory support [14, 15]. Second, hyper-catabolism re-
lated to sustained endobronchial lung suppuration and high 
levels of respiratory muscle recruitment increases CO2 pro-
duction [16, 17]. Third, the strikingly high levels of hyper-
capnia indicate the difficulty we had providing ample ven-
tilation to these patients. High airway resistance secondary 
to secretions, airway inflammation, and obliterated bronchi 
leads to elevated peak pressures, a tendency for air trapping, 
and ultimately, inadequate alveolar ventilation [16].  
The clinical management of CF is unique, complicated 
and multi-faceted. Once entering adulthood, CF patients also 
maintain autonomy in deciding the extent and limits of their 
health care and treatments. The purpose of our review was 
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not to debate the merits or ethics of acute invasive mechani-
cal ventilation in CF patients with severe chronic end organ 
disease but rather to highlight specific clinical observations 
of critically ill CF patients, all of whom died in the MICU 
[18, 19].  
Given the consistently reported high mortality of criti-
cally ill adult CF patients requiring invasive mechanical ven-
tilation, it is of paramount importance to institute timely and 
optimal management and support of organ systems failure 
while acknowledging the absence of evidence-based prac-
tice guidelines. This is especially important when the initia-
tion of invasive mechanical ventilation is used as a bridge to 
lung transplantation. 
Until studies are performed that better define the com-
plex gas exchange in acute respiratory failure in CF and an 
approach to invasive ventilation for CF patients requiring 
this therapy is validated, awareness of these observations 
should assist current clinical practice guidelines.
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